Fiduciary Family Office, LLC Abb Vie Inc. Transaction History

Fiduciary Family Office, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$163.84 - $199.33 $35,389 - $43,055	-216 Reduced 3.02%	6,926 $1.37 Billion
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $404,466 - $472,325	-2,613 Reduced 26.79%	7,142 $1.22 Billion
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $48,105 - $54,812	301 Added 3.18%	9,755 $1.78 Billion
Q4 2023 May 07, 2024	BUY	$137.6 - $154.97 $1.3 Million - $1.47 Million	9,454 New	9,454 $1.47 Billion

3,975

1.26B

16.4M

12.9M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $339B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fiduciary Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Family Office, LLC with notifications on news.